C
ANI Pharmaceuticals, Inc. ANIP
$61.43 -$2.34-3.67%
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)
Weiss Ratings ANIP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Rating C
Reward Index Good
Risk Index Weak
Risk Grade D+
Reward Grade B
Rating Factors ANIP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Dividend Index --
Growth Index Good
Efficiency Index Fair
Solvency Index Excellent
Total Return Index Good
Volatility Index Fair
Beta / Standard Deviation ANIP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Beta 0.63
Price History ANIP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
7-Day Total Return -6.75%
30-Day Total Return -9.11%
60-Day Total Return 3.89%
90-Day Total Return 8.53%
Year to Date Total Return 7.41%
1-Year Total Return 32.36%
2-Year Total Return 110.52%
3-Year Total Return 71.81%
5-Year Total Return -11.31%
52-Week High % Change -13.25%
52-Week Low % Change 39.41%
Price ANIP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
52-Week High Price $70.81
52-Week Low Price $44.07
52-Week Low Price (Date) May 18, 2023
52-Week High Price (Date) Mar 25, 2024
Valuation ANIP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Market Cap 1.19B
Enterprise Value 1.27B
Price/Earnings (TTM) 38.30
Earnings Per Share (TTM) 1.60
Earnings Per Share Growth -192.64%
Price/Earnings To Growth --
Price/Sales (TTM) 2.31
Price/Book (Q) 2.64
Enterprise Value/Revenue (TTM) 2.45
Price $61.43
Enterprise Value/EBITDA (TTM) 11.30
Enterprise Value/EBIT 24.13
Market Cap Category Small Cap
Dividends and Shares ANIP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Shares Outstanding 19.42M
Dividend Yield --
Div. Per Share (Most Recent) --
Dividend Per Share (TTM) --
Payout Ratio (TTM) 4.57%
Dividend Per Share (Most Recent) --
Company Info ANIP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Phone Number 218 634 3500
Address 210 Main Street West Baudette, MN 56623
Website www.anipharmaceuticals.com
Country United States
Year Founded 2001
Profitability ANIP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Operating Margin (TTM) 10.16%
Profit Margin 6.86%
Management Effectiveness ANIP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Return on Assets 3.91%
Return on Equity 8.71%
Income Statement ANIP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Revenue (TTM) 517.46M
Total Revenue (TTM) 517.46M
Revenue Per Share $26.64
Gross Profit (TTM) 324.50M
EBITDA (TTM) 112.38M
EBIT (TTM) 52.60M
Net Income (TTM) 35.55M
Net Income Avl. to Common (TTM) 33.92M
Total Revenue Growth (Q YOY) 28.70%
Earnings Growth (Q YOY) 1,165.25%
EPS Diluted (TTM) 1.60
EPS Diluted Growth (Q YOY) 1,381.15%
Balance Sheet ANIP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash and Short-Term Inv. (Q) 238.25M
Cash Per Share (Q) $12.27
Total Current Assets (Q) 540.56M
Total Preferred Equity (Q) 24.85
Total Equity (Q) 476.81M
Current Ratio (Q) 3.949
Book Value Per Share (Q) $23.26
Total Assets (Q) 914.52M
Total Current Liabilities (Q) 136.89M
Total Debt (Q) 290.51M
Total Liabilities (Q) 437.71M
Total Common Equity (Q) 451.96M
Cash Flow ANIP - NASDAQ Click to
Compare
Click to
Compare
Click to
Compare
Cash from Investing (TTM) -7.23M
Cash from Financing (TTM) 52.26M
Net Change in Cash (TTM) 160.84M
Levered Free Cash Flow (TTM) 79.33M
Cash from Operations (TTM) 115.80M
Weiss Ratings